Tricida, Inc. – NASDAQ:TCDA

Add to watchlist

$0.108

Market open

Closed in about 3 hours

-34.90%

month

-62.34%

quarter

-98.97%

year

Market Cap	5.95M
Enterprise value	196.51M

P/E	-0.02
EV/Sales	N/A
EV/EBITDA	-1.59
Price/Sales	N/A
Price/Book	-0.04
PEG ratio	N/A
EPS	-2.56

Revenue	N/A
EBITDA	-123.59M
Income	-143.90M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Tricida, Inc. (NASDAQ:TCDA): Profit margin
Dec 2021	0	-54.04M
Mar 2022	0	-31.61M
Jun 2022	0	-30.51M
Sep 2022	0	-27.73M

Tricida, Inc. (NASDAQ:TCDA): Earnings per share (EPS)
2022-08-08	-0.58	-0.49
2022-11-14	-0.54	-0.44

Tricida, Inc. (NASDAQ:TCDA): Debt to assets
Dec 2021	168506000	168.28M	99.87%
Mar 2022	140414000	230.71M	164.31%
Jun 2022	114288000	225.51M	197.32%
Sep 2022	93879000	229.97M	244.97%

Tricida, Inc. (NASDAQ:TCDA): Cash Flow
Dec 2021	-38.06M	230K	41.95M
Mar 2022	-26.40M	23.19M	-190K
Jun 2022	-25.58M	29.38M	639K
Sep 2022	-18.74M	14.28M	53K

Tricida alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Tricida, Inc. (NASDAQ:TCDA): Employee count
Aug 2023	57
Sep 2023	57
Oct 2023	57
Nov 2023	57
Dec 2023	57
Jan 2024	57
Feb 2024	57
Mar 2024	57
Apr 2024	57
May 2024	57
Jun 2024	57
Jul 2024	57

Tricida
Hedge Funds Holdings Q1 2022

79.90% +5.56%

of TCDA is owned by hedge funds

92 +9

hedge funds hold TCDA stock

40.97M +3.48M

shares is hold by hedge funds

TCDA hedge funds holdings changes

Tricida, Inc. (NASDAQ:TCDA): Insider trades (number of shares)
Period	Buy	Sel
Dec 2021	0	35203
Apr 2022	0	46099
Jun 2022	1457790	0
Jul 2022	425872	0
Aug 2022	50000	284939
Sep 2022	1442113	0
Oct 2022	1152882	6880534
Nov 2022	0	18652515

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	25 Nov 2022	ORBIMED ADVISORS LLC director, 10 percent owner director, 10 percent owner	Common Stock	3,629,226	$0.22	$798,430
Sale	25 Nov 2022	BONITA DAVID P director, 10 percent owner director, 10 percent owner	Common Stock	3,629,226	$0.22	$798,430
Sale	23 Nov 2022	ALPERN ROBERT J director director	Common Stock	131,879	$0.21	$27,695
Sale	23 Nov 2022	ORBIMED ADVISORS LLC director, 10 percent owner director, 10 percent owner	Common Stock	5,617,300	$0.21	$1,179,633
Sale	23 Nov 2022	BONITA DAVID P director, 10 percent owner director, 10 percent owner	Common Stock	5,617,300	$0.21	$1,179,633
Sale	21 Nov 2022	ALPERN ROBERT J director director	Common Stock	27,584	$0.23	$6,344
Sale	26 Oct 2022	VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. 10 percent ow.. 10 percent owner	Common Stock	2,367,174	$0.46	$1,088,900
Sale	25 Oct 2022	VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. 10 percent ow.. 10 percent owner	Common Stock	1,970,418	$0.57	$1,123,138
Sale	24 Oct 2022	VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. 10 percent ow.. 10 percent owner	Common Stock	2,113,948	$0.61	$1,289,508
Purchase	19 Oct 2022	VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. 10 percent ow.. 10 percent owner	Common Stock	70,100	$11.25	$788,625

Status	Patent	Filling date	Issue date
Grant	Grant Utility: HCl-binding compositions for and methods of treating acid-base disorders Filling date: 5 May 2017 Issue date: 9 Aug 2022	5 May 2017	9 Aug 2022
Grant	Grant Utility: Proton-binding polymers for oral administration Filling date: 10 Dec 2015 Issue date: 26 Apr 2022	10 Dec 2015	26 Apr 2022
Application	Application PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION Filling date: 9 Dec 2021 Issue date: 31 Mar 2022	9 Dec 2021	31 Mar 2022
Grant	Grant Utility: Compositions for and method of treating acid-base disorders Filling date: 3 Nov 2018 Issue date: 8 Mar 2022	3 Nov 2018	8 Mar 2022
Application	Application COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS Filling date: 24 Sep 2021 Issue date: 3 Mar 2022	24 Sep 2021	3 Mar 2022
Grant	Grant Utility: Proton-binding polymers for oral administration Filling date: 16 Aug 2019 Issue date: 14 Dec 2021	16 Aug 2019	14 Dec 2021
Application	Application CROSSLINKED POLY(ALLYLAMINE) POLYMER PHARMACEUTICAL COMPOSITIONS Filling date: 11 Jan 2021 Issue date: 11 Nov 2021	11 Jan 2021	11 Nov 2021
Application	Application COMPOSITIONS FOR TREATING ACID-BASE DISORDERS Filling date: 4 Mar 2021 Issue date: 8 Jul 2021	4 Mar 2021	8 Jul 2021
Application	Application METHOD OF TREATING ACID-BASE DISORDERS Filling date: 3 Nov 2018 Issue date: 24 Jun 2021	3 Nov 2018	24 Jun 2021
Application	Application METHOD OF TREATING ACID-BASE DISORDERS Filling date: 3 Dec 2020 Issue date: 15 Apr 2021	3 Dec 2020	15 Apr 2021

Tricida
Earnings Call Transcripts

Quarter	Transcript
Q2 2022 8 Aug 2022	Q2 2022 Earnings Call Transcript
Q1 2022 14 May 2022	Q1 2022 Earnings Call Transcript
Q4 2021 29 Mar 2022	Q4 2021 Earnings Call Transcript
Q3 2021 8 Nov 2021	Q3 2021 Earnings Call Transcript

TCDA earnings call transcripts

Tricida
Executives

Insider	Age	Compensation
Dr. Gerrit Klaerner Ph.D. (1971) Founder, Pres, Chief Executive Officer & Executive Director	54	$719,980
Dr. Dawn Parsell Ph.D. (1962) Executive Vice President of Clinical Devel.	63	$504,920
Mr. Geoffrey M. Parker (1965) Chief Operating Officer, Chief Financial Officer & Executive Vice President	60	$502,330
Dr. Wilhelm Stahl (1960) Executive Vice President & Chief Technology Officer	65	$472,060

Tricida
Latest News

Wednesday, 8 February 2023
19:00	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Tricida, Inc.	newsfilecorp.com
Thursday, 12 January 2023
14:46	Tricida files for Chapter 11 bankruptcy protection as it searches for a buyer	Proactive Investors
Wednesday, 30 November 2022
11:18	Top 10 most-shorted stocks as of November 2022	Finbold
Sunday, 27 November 2022
11:00	What Penny Stocks Industries Are Popular Right Now?	PennyStocks
Tuesday, 8 November 2022
06:00	What to Look For in Penny Stocks Under $1, 3 Tips	PennyStocks
Monday, 7 November 2022
06:00	Buying Cheap Penny Stocks in November? 3 Tips to Use	PennyStocks
Saturday, 5 November 2022
11:00	Top Reasons You're Not Making Money With Penny Stocks	PennyStocks
Monday, 24 October 2022
11:18	Why Is Tricida (TCDA) Stock Down 90% Today?	InvestorPlace
Wednesday, 21 September 2022
08:00	Tricida: Important Binary Event Coming Up	Seeking Alpha
Tuesday, 6 September 2022
10:00	Tricida to Present at the H.C. Wainwright 24th Annual Global Investment Conference	Business Wire
Monday, 8 August 2022
21:00	Tricida, Inc. (TCDA) CEO Gerrit Klaerner on Q2 2022 Results - Earnings Call Transcript	Seeking Alpha
Monday, 1 August 2022
10:00	Tricida to Report Second Quarter Financial Results and Host Conference Call and Webcast on Monday, August 8, 2022	GlobeNewsWire
Saturday, 14 May 2022
23:29	Tricida, Inc. (TCDA) CEO Gerrit Klaerner on Q1 2022 Results - Earnings Call Transcript	Seeking Alpha
Tuesday, 3 May 2022
10:00	Tricida to Report First Quarter Financial Results and Host Conference Call and Webcast on Tuesday, May 10, 2022	GlobeNewsWire
Friday, 1 April 2022
10:00	Tricida to Present at the Needham Virtual Healthcare Conference	GlobeNewsWire
Tuesday, 29 March 2022
18:42	Tricida, Inc. (TCDA) CEO Gerrit Klaerner on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
Wednesday, 16 March 2022
10:00	Tricida to Report Fourth Quarter Financial Results and Host Conference Call and Webcast on Tuesday, March 29, 2022	GlobeNewsWire
Wednesday, 15 December 2021
13:58	Tricida to Present at the 40th Annual J.P. Morgan Healthcare Conference	GlobeNewsWire
Tuesday, 16 November 2021
15:41	Tricida (TCDA) Stock: Why The Price Jumped Today	Pulse2
11:38	Why Tricida Stock Is Jumping Today	The Motley Fool
Monday, 15 November 2021
15:12	Tricida (TCDA) Stock: Why The Price Jumped Today	Pulse2
Monday, 8 November 2021
18:47	Tricida, Inc. (TCDA) CEO Gerrit Klaerner on Q3 2021 Results - Earnings Call Transcript	Seeking Alpha
Tuesday, 2 November 2021
10:00	Tricida to Report Third Quarter Financial Results and Host Conference Call and Webcast on Monday, November 8, 2021	GlobeNewsWire
Tuesday, 7 September 2021
10:30	Tricida to Present at the H.C. Wainwright 23rd Annual Global Investment Conference	GlobeNewsWire

Ideas & Opinions

Seeking Alpha 21 Sep 2022

Tricida: Important Binary Event Coming Up

Frequently Asked Questions (FAQ)

What's the price of Tricida stock today?

One share of Tricida stock can currently be purchased for approximately $0.11.
When is Tricida's next earnings date?

Unfortunately, Tricida's (TCDA) next earnings date is currently unknown.
Does Tricida pay dividends?

No, Tricida does not pay dividends.
How much money does Tricida make?

Tricida has a market capitalization of 5.95M. Tricida made a loss 194.17M US dollars in net income (profit) last year or -$0.44 on an earnings per share basis.
What is Tricida's stock symbol?

Tricida, Inc. is traded on the NASDAQ under the ticker symbol "TCDA".
What is Tricida's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Tricida?

Shares of Tricida can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Tricida's key executives?
Tricida's management team includes the following people:
- Dr. Gerrit Klaerner Ph.D. Founder, Pres, Chief Executive Officer & Executive Director(age: 54, pay: $719,980)
- Dr. Dawn Parsell Ph.D. Executive Vice President of Clinical Devel.(age: 63, pay: $504,920)
- Mr. Geoffrey M. Parker Chief Operating Officer, Chief Financial Officer & Executive Vice President(age: 60, pay: $502,330)
- Dr. Wilhelm Stahl Executive Vice President & Chief Technology Officer(age: 65, pay: $472,060)
Is Tricida founder-led company?

Yes, Tricida is a company led by its founder Dr. Gerrit Klaerner Ph.D..
How many employees does Tricida have?

As Jul 2024, Tricida employs 57 workers.
When Tricida went public?

Tricida, Inc. is publicly traded company for more then 7 years since IPO on 28 Jun 2018.
What is Tricida's official website?

The official website for Tricida is tricida.com.
Where are Tricida's headquarters?

Tricida is headquartered at 7000 Shoreline Court, South San Francisco, CA.
How can i contact Tricida?

Tricida's mailing address is 7000 Shoreline Court, South San Francisco, CA and company can be reached via phone at +41 54297800.

Tricida, Inc.

tricida.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

+41 54297800

7000 Shoreline Court
South San Francisco, CA 94080

CIK: 0001595585
ISIN: US89610F1012
CUSIP: 89610F101